1. Background
2. Objectives
3. Methods
| Anthropometric Landmark | Definition |
|---|---|
| Alar, al | The most lateral point of nasal ala |
| Chelion, ch | The point at which outer ends of the upper and lower lip meet, The outer corner of the mouth where the outer edges of the upper and lower vermilions meet |
| Crista philtre, cp | The point on the crest of the philtrum, the vertical groove in the median portion of the upper lip, just above the vermilion border |
| Endocanthion, en | The point at which the inner ends of the upper and the lower eyelid meet |
| Exocantion, ex | The point at which the outer ends of the upper and the lower eyelid meet |
| Frontotemporale, ft | The most medial point on the temporal crest of the frontal bone |
| Frontozygomatic, fz | The most lateral point on the frontozygomatic suture |
| Glabella, gl | Most forward-projecting point of the forehead in the midline of the supraorbital ridges |
| Gnathion, gn | In the midline, the lowest point on the lower border of the chin |
| Gonion, go | The most lateral point at the angle of the mandible |
| Labiale inferior, li | The midpoint of the vermilion border of the lower lip |
| Labiale, ls | The midpoint of the vermilion border of the upper lip |
| Maxillofrontale, mf | The anterior lacrimal crest of the maxilla at the frontomaxillary suture |
| Nasion, n | The midpoint of the nasofrontal suture |
| Postaurel, pa | The most posterior point of the ear |
| Preaurel, pra | The most anterior point of the ear |
| Pronasale, prn | The most prominent anterior point on the nasal tip |
| Pupil, p | Lower point of circumference of pupil |
| Stomion, st | The midpoint of the labial fissure when the lips are closed naturally |
| Subalar, sa | Labial insertion points of the alar base |
| Subaurel, sba | The most inferior point of the ear |
| Sublabial, sl | The midpoint of the labiomental sulcus |
| Subnasale, sn | The midpoint at the base of the columella |
| Superaurel, spa | The most superior point of the ear |
| Tragion, tr | Located just above the tragus of the ear |
| Trichion, t | The midpoint of the hairline |
| Vertex, v | The highest point of the cranium |
| Zygion, z | The most lateral point on the zygomatic arch |
| Measurements | |
|---|---|
| Head height (between the highest point of the cranium and nasion) | v-n |
| Between the tragion and nasion | t-n |
| Calva height | v-t |
| Physiognomic face height | t-gn |
| A) Upper face height/forehead height | t-gl |
| B) Middle face height | gl-sn |
| C) Lower face height | sn-gn |
| Morphologic face height | n-gn |
| A) Upper face height | n-st |
| 1. Nose height | n-sn |
| 2. Upper lip height | sn-st |
| a. Philtrum length | sn-ls |
| b. Upper vermilion height | ls-st |
| B) Lower face height | st-gn |
| 1. Lower lip height | st-sl |
| a. Cutaneous lower lip height | li-sl |
| b. Lower vermilion height | li-st |
| 2. Chin height | sl-gn |
| Nasal bridge length | n-prn |
| Minimum frontal breadth | ft-ft |
| Supraorbital breadth | fz-fz |
| Nasal root width | mf-mf |
| Biocular width | ex-ex |
| Eye fissure width | ex-en |
| Interocular distance (intercanthal width) | en-en |
| Distance from the lower point of circumference of pupils | p-p |
| Maximum facial breadth | z-z |
| Bitragal width | tr-tr |
| Nose width | al-al |
| Nostril floor width | sa-sn |
| Philtrum width | cp-cp |
| Mouth width (labial fissure width) | ch-ch |
| Lower face width (mandible width) | go-go |
| Between the subnasale and pronasale | sn-prn |
| Between the tragion and nasion | tr-n |
| Middle face depth (maxillary depth) | tr-sn |
| Lower face depth (mandibular depth) | tr-gn |
| Ear length | spa-sba |
| Ear width | pra-pa |
| Angle | Definition |
|---|---|
| Nasofrontal angle, nfra | The glabella through the nasion that intersect a line drawn tangent to nasal dorsum |
| Nasofacial angle, nfca | Formed by drawing a vertical line tangent to the forehead at the glabella and tangent to the chin at pogonion (the most anterior point on the contour of the chin located midway between pogonion and menton) so that a line drawn along the nasal dorsum intersects it |
| Nasomental angle, nma | Formed by a line drawn through the nasal dorsum intersecting a line drawn from the nasal tip to soft tissue chin (pogonion) |
| Nasolabial angle, nla | Corresponds to the angle, whose vertex is the subnasale, lying in a tangent line to the nasal tip and another tangent line to the upper lip |
| Ear incline angle, eia | The angle between vertical axis and the subaurel-superaurel line |
| Parameter | Celiac Disease | Control Group | Pb | Adjusted Pc |
|---|---|---|---|---|
| t-gl/t-gn | 0.29 ± 0.04 | 0.28 ± 0.03 | 0.001d | 0.001d |
| gl-sn/t-gn | 0.37 ± 0.03 | 0.37 ± 0.02 | 0.581 | 0.375 |
| sn-gn/t-gn | 0.33 ± 0.04 | 0.35 ± 0.03 | 0.001d | 0.001d |
| n-sn/t-gn | 0.31 ± 0.03 | 0.30 ± 0.02 | 0.001d | 0.001d |
| v-t/t-gn | 0.11 ± 0.03 | 0.11 ± 0.03 | 0.832 | 0.993 |
| sn-st/t-gn | 0.12 ± 0.02 | 0.12 ± 0.01 | 0.809 | 0.415 |
| st-sl/t-gn | 0.09 ± 0.01 | 0.10 ± 0.01 | 0.071 | 0.331 |
| ls-st/sn-st | 0.25 ± 0.07 | 0.27 ± 0.06 | 0.101 | 0.221 |
| li-st/st-sl | 0.50 ± 0.13 | 0.45 ± 0.10 | 0.020d | 0.020d |
| en-en/z-z | 0.27 ± 0.02 | 0.27 ± 0.02 | 0.226 | 0.343 |
| en-en/ex-ex | 0.38 ± 0.02 | 0.38 ± 0.02 | 0.388 | 0.434 |
| ft-ft/z-z | 0.80 ± 0.05 | 0.82 ± 0.05 | 0.001d | 0.001d |
| fz-fz/z-z | 0.88 ± 0.03 | 0.86 ± 0.04 | 0.001d | 0.001d |
| go-go/z-z | 0.77 ± 0.04 | 0.77 ± 0.04 | 0.540 | 0.261 |
| ex-en (R)/z-z | 0.23 ± 0.02 | 0.22 ± 0.01 | 0.371 | 0.246 |
| ex-en (L)/z-z | 0.23 ± 0.01 | 0.22 ± 0.01 | 0.749 | 0.741 |
| al-al/z-z | 0.26 ± 0.02 | 0.27 ± 0.02 | 0.003d | 0.026d |
| ch-ch/z-z | 0.36 ± 0.03 | 0.38 ± 0.03 | 0.001d | 0.001d |
| en-en/al-al | 1.03 ± 0.09 | 1.01 ± 0.10 | 0.108 | 0.292 |
| en-en/ex-en (R) | 1.20 ± 0.11 | 1.22 ± 0.12 | 0.122 | 0.125 |
| en-en/ex-en (L) | 1.20 ± 0.11 | 1.22 ± 0.12 | 0.427 | 0.577 |
| al-al/ch-ch | 0.74 ± 0.08 | 0.72 ± 0.06 | 0.037d | 0.054 |
| ch-ch/en-en | 1.33 ± 0.15 | 1.40 ± 0.15 | 0.002d | 0.009d |
| ch-ch/ex-ex | 0.50 ± 0.04 | 0.53 ± 0.04 | 0.001d | 0.001d |
| sa-sn (R)/al-al | 0.47 ± 0.05 | 0.50 ± 0.04 | 0.001d | 0.001d |
| sa-sn (L)/al-al | 0.46 ± 0.05 | 0.50 ± 0.04 | 0.001d | 0.001d |
| cp-cp/al-al | 0.30 ± 0.05 | 0.30 ± 0.05 | 0.348 | 0.355 |
| cp-cp/z-z | 0.08 ± 0.01 | 0.08 ± 0.01 | 0.570 | 0.900 |
| cp-cp/go-go | 0.10 ± 0.02 | 0.11 ± 0.02 | 0.524 | 0.713 |
| t-n/p-p | 1.03 ± 0.15 | 1.00 ± 0.14 | 0.231 | 0.353 |
| al-al/n-sn | 0.60 ± 0.07 | 0.64 ± 0.07 | 0.001d | 0.001d |
| t-n/n-sn | 1.14 ± 0.18 | 1.13 ± 0.15 | 0.758 | 0.845 |
| z-z/t-gn | 0.72 ± 0.04 | 0.70 ± 0.05 | 0.014d | 0.041d |
| n-gn/z-z | 0.33 ± 0.03 | 0.33 ± 0.03 | 0.864 | 0.864 |
| tr-n/tr-sn | 1.06 ± 0.04 | 1.06 ± 0.05 | 0.742 | 0.206 |
| tr-sn/tr-gn | 0.95 ± 0.05 | 0.90 ± 0.05 | 0.001d | 0.001d |
| tr-n/tr-gn | 1.02 ± 0.08 | 0.96 ± 0.07 | 0.001d | 0.001d |
| spa-sba/t-gn | 0.33 ± 0.03 | 0.33 ± 0.03 | 0.864 | 0.787 |
Abbreviations: L, left; R, right.
aValues are expressed as mean ± SD.
bStudent t-test.
cAdjusted P values for age and gender
dSignificant at 0.05 level.
3.1. Statistical Analyses
4. Results
| Parameter | Celiac Disease | Control Group | Pc | Adjusted Pd |
|---|---|---|---|---|
| v-n | 77.57 ± 8.49 | 79.90 ± 7.65 | 0.001e | 0.128 |
| v-t | 18.38 ± 4.09 | 19.33 ± 4.38 | 0.115 | 0.178 |
| t-gl | 48.33 ± 7.23 | 48.43 ± 7.39 | 0.922 | 0.734 |
| t-n | 58.02 ± 8.14 | 59.06 ± 8.24 | 0.370 | 0.578 |
| n-st | 70.11 ± 6.82 | 73.61 ± 4.98 | 0.001e | 0.001e |
| gl-sn | 60.82 ± 7.13 | 64.37 ± 5.25 | 0.001e | 0.001e |
| sn-gn | 54.62 ± 6.63 | 61.60 ± 5.79 | 0.001e | 0.001e |
| st-gn | 35.25 ± 5.02 | 40.78 ± 4.73 | 0.001e | 0.001e |
| t-gn | 164.20 ± 13.39 | 175.00 ± 13.06 | 0.001e | 0.001e |
| n-gn | 106.52 ± 10.52 | 114.99 ± 8.31 | 0.001e | 0.001e |
| sl-gn | 20.45 ± 3.77 | 23.60 ± 3.04 | 0.001e | 0.001e |
| ft-ft | 93.63 ± 6.56 | 100.74 ± 6.18 | 0.001e | 0.001e |
| z-z | 117.75 ± 6.59 | 122.71 ± 6.66 | 0.001e | 0.001e |
| p-p | 56.73 ± 4.39 | 59.00 ± 3.66 | 0.001e | 0.003e |
| en-en | 31.74 ± 2.89 | 33.50 ± 3.01 | 0.001e | 0.001e |
| ex-en (R) | 26.58 ± 2.11 | 27.46 ± 1.66 | 0.001e | 0.032e |
| ex-en (L) | 26.47 ± 2.04 | 27.66 ± 1.92 | 0.001e | 0.001e |
| ex-ex | 84.60 ± 5.65 | 88.68 ± 5.11 | 0.001e | 0.001e |
| fz-fz | 103.20 ± 6.23 | 105.54 ± 5.72 | 0.006e | 0.125 |
| go-go | 90.60 ± 7.46 | 93.99 ± 7.76 | 0.002e | 0.034e |
| n-sn | 51.44 ± 6.15 | 52.23 ± 4.40 | 0.297 | 0.827 |
| n-prn | 42.91 ± 5.89 | 42.38 ± 4.52 | 0.473 | 0.054 |
| al-al | 30.81 ± 3.00 | 33.22 ± 3.05 | 0.001e | 0.001e |
| mf-mf | 21.11 ± 2.17 | 18.31 ± 2.18 | 0.001e | 0.001e |
| sa-sn (R) | 14.55 ± 2.13 | 16.73 ± 2.06 | 0.001e | 0.001e |
| sa-sn (L) | 14.21 ± 2.21 | 16.56 ± 2.00 | 0.001e | 0.001e |
| sn-ls | 15.42 ± 2.29 | 15.70 ± 2.17 | 0.366 | 0.519 |
| cp-cp | 9.42 ± 1.56 | 9.95 ± 1.81 | 0.028e | 0.158 |
| ls-st | 4.90 ± 1.61 | 5.52 ± 1.32 | 0.003e | 0.016e |
| li-st | 7.52 ± 2.12 | 7.63 ± 2.01 | 0.688 | 0.639 |
| sn-st | 19.25 ± 2.40 | 20.62 ± 2.52 | 0.001e | 0.001e |
| st-sl | 15.43 ± 2.31 | 16.98 ± 2.46 | 0.001e | 0.001e |
| li-sl | 7.38 ± 2.06 | 8.56 ± 2.21 | 0.001e | 0.002e |
| ch-ch | 42.02 ± 4.43 | 46.59 ± 4.94 | 0.001e | 0.001e |
| tr-tr | 126.64 ± 7.43 | 134.19 ± 7.06 | 0.001e | 0.001e |
| sn-prn | 15.86 ± 2.49 | 17.56 ± 2.28 | 0.001e | 0.001e |
| tr-n | 99.81 ± 7.70 | 98.93 ± 7.58 | 0.428 | 0.020e |
| tr-sn | 93.80 ± 8.70 | 92.83 ± 8.88 | 0.449 | 0.009e |
| tr-gn | 98.87 ± 11.24 | 103.20 ± 9.73 | 0.005e | 0.122 |
| spa-sba | 54.28 ± 4.89 | 57.57 ± 4.32 | 0.001e | 0.001e |
| pra-pa | 36.19 ± 3.32 | 38.41 ± 3.39 | 0.001e | 0.001e |
| nfra | 142.16 ± 7.30 | 138.77 ± 7.73 | 0.002e | 0.001e |
| nfca | 37.44 ± 3.75 | 35.60 ± 3.29 | 0.001e | 0.002e |
| nma | 125.91 ± 4.15 | 127.37 ± 4.33 | 0.017e | 0.030e |
| nla | 111.99 ± 10.02 | 113.19 ± 9.82 | 0.401 | 0.236 |
| eia | 27.31 ± 5.73 | 26.59 ± 4.43 | 0.348 | 0.306 |
Abbreviations: L, left; R, right.
aValues are expressed as mean ± SD.
bThe first 41 parameters are given as millimeter, mm; the last 5 parameters are given as angle, º.
cStudent t-test.
dAdjusted P values for age and gender.
eSignificant at 0.05 level.
5. Discussion
| Children with Celiac Disease, mm | Healthy Children, mm | P Value | |
|---|---|---|---|
| n-sn | |||
| Selimoglu et al. (16) | 45.7 ± 9.0 | 37.5 ± 7.5 | < 0.0001a |
| Zanchi et al. (18) | 47.30 ± 18.0 | 53.0 ± 20.0 | 0.130 |
| Present study | 51.44 ± 6.15 | 52.23 ± 4.40 | 0.827 |
| sn-gn | |||
| Selimoglu et al. (16) | 49.0 ± 8.8 | 38.5 ± 9.3 | < 0.0001a |
| Zanchi et al. (18) | 59.0 ± 21.2 | 67.2 ± 27.0 | 0.068 |
| Present study | 54.62 ± 6.63 | 61.60 ± 5.79 | 0.001a |
| t-gn | |||
| Selimoglu et al. (16) | 154.6 ± 27.2 | 125.7 ± 23.3 | < 0.0001a |
| Zanchi et al. (18) | 168.9 ± 60.0 | 190.7 ± 74.3 | 0.080 |
| Present study | 164.20 ± 13.39 | 175.00 ± 13.06 | 0.001a |
| t-gl | |||
| Selimoglu et al. (16) | 47.5 ± 11.1 | 38.5 ± 7.7 | < 0.0001a |
| Present study | 48.33 ± 7.23 | 48.43 ± 7.39 | 0.734 |
| n-prn | |||
| Selimoglu et al. (16) | 35.1 ± 7.7 | 30.2 ± 6.4 | < 0.0001a |
| Present study | 42.91 ± 5.89 | 42.38 ± 4.52 | 0.054 |
| v-t | |||
| Selimoglu et al. (16) | 27.8 ± 8.5 | 19.2 ± 5.2 | < 0.0001a |
| Present study | 18.38 ± 4.09 | 19.33 ± 4.38 | 0.178 |
| gl-sn | |||
| Selimoglu et al. (16) | 58.0 ± 11.6 | 48.7 ± 10.2 | < 0.0001a |
| Present study | 60.82 ± 7.13 | 64.37 ± 5.25 | 0.001a |
| spa-sba | |||
| Selimoglu et al. (16) | 46.2 ± 7.5 | 36.7 ± 10.4 | < 0.0001a |
| Present study | 54.28 ± 4.89 | 57.57 ± 4.32 | 0.001a |
| ch-ch | |||
| Selimoglu et al. (16) | 39.9 ± 6.9 | 35.1 ± 7.7 | < 0.0001a |
| Present study | 42.02 ± 4.43 | 46.59 ± 4.94 | 0.001a |
| z-z | |||
| Selimoglu et al. (16) | 111.2 ± 17.5 | 88.0 ± 17.81 | < 0.0001a |
| Present study | 117.75 ± 6.59 | 122.71 ± 6.66 | 0.001a |
| al-al | |||
| Selimoglu et al. (16) | 27.6 ± 4.8 | 23.2 ± 4.9 | < 0.0001a |
| Present study | 30.81 ± 3.00 | 33.22 ± 3.05 | 0.001a |
| nfra | |||
| Selimoglu et al. (16) | 144.6 ± 10.0 | 146.0 ± 13.6 | 0.134 |
| Present study | 142.16 ± 7.30 | 138.77 ± 7.73 | 0.001a |
| nla | |||
| Selimoglu et al. (16) | 105.3 ± 15.8 | 107.0 ± 11.3 | 0.308 |
| Present study | 111.99 ± 10.02 | 113.19 ± 9.82 | 0.236 |
| en-en | |||
| Selimoglu et al. (16) | 29.8 ± 5.2 | 24.8 ± 5.4 | < 0.0001a |
| Present study | 31.74 ± 2.89 | 33.50 ± 3.01 | 0.001a |
| ex-ex | |||
| Selimoglu et al. (16) | 82.5 ± 14.4 | 70.0 ± 13.2 | < 0.0001a |
| Present study | 84.60 ± 5.65 | 88.68 ± 5.11 | 0.001a |
| ex-en | |||
| Selimoglu et al. (16) | 27.6 ± 4.7 | 23.3 ± 4.7 | < 0.0001a |
| Present study, right | 26.58 ± 2.11 | 27.46 ± 1.66 | 0.032a |
| Present study, left | 26.47 ± 2.04 | 27.66 ± 1.92 | 0.001a |
aSignificance level = 0.05
| Children with Celiac Disease | Healthy Children | P Value | |
|---|---|---|---|
| t-gl/t-gn | |||
| Selimoglu et al. (16) | 0.31 ± 0.04 | 0.31 ± 0.04 | 0.710 |
| Present study | 0.29 ± 0.04 | 0.28 ± 0.03 | 0.001a |
| gl-sn/t-gn | |||
| Selimoglu et al. (16) | 0.37 ± 0.03 | 0.39 ± 0.04 | 0.002a |
| Present study | 0.37 ± 0.03 | 0.37 ± 0.02 | 0.375 |
| sn-gn/t-gn | |||
| Selimoglu et al. (16) | 0.32 ± 0.03 | 0.31 ± 0.04 | 0.045a |
| Zanchi et al. (18) | 0.35 ± 0.02 | 0.35 ± 0.03 | 0.760 |
| Present study | 0.33 ± 0.04 | 0.35 ± 0.03 | 0.001a |
| n-sn/t-gn | |||
| Selimoglu et al. (16) | 0.30 ± 0.02 | 0.30 ± 0.03 | 0.359 |
| Zanchi et al. (18) | 0.28 ± 0.02 | 0.28 ± 0.02 | 0.880 |
| Present study | 0.31 ± 0.03 | 0.30 ± 0.02 | 0.001a |
| spa-sba/t-gn | |||
| Selimoglu et al. (16) | 0.30 ± 0.03 | 0.29 ± 0.06 | 0.001a |
| Present study | 0.33 ± 0.03 | 0.33 ± 0.03 | 0.787 |
| v-t/t-gn | |||
| Selimoglu et al. (16) | 0.19 ± 0.07 | 0.15 ± 0.04 | 0.001a |
| Present study | 0.11 ± 0.03 | 0.11 ± 0.03 | 0.993 |
| z-z/t-gn | |||
| Selimoglu et al. (16) | 0.72 ± 0.09 | 0.70 ± 0.07 | 0.014a |
| Present study | 0.72 ± 0.04 | 0.70 ± 0.05 | 0.041a |
| en-en/z-z | |||
| Selimoglu et al. (16) | 0.27 ± 0.07 | 0.28 ± 0.05 | < 0.0001a |
| Present study | 0.27 ± 0.02 | 0.27 ± 0.02 | 0.343 |
| ex-en/z-z | |||
| Selimoglu et al. (16) | 0.25 ± 0.05 | 0.27 ± 0.04 | < 0.0001a |
| Present study, right | 0.23 ± 0.02 | 0.22 ± 0.01 | 0.246 |
| Present study, left | 0.23 ± 0.01 | 0.22 ± 0.01 | 0.741 |
| al-al/z-z | |||
| Selimoglu et al. (16) | 0.25 ± 0.06 | 0.27 ± 0.05 | < 0.0001a |
| Present study | 0.26 ± 0.02 | 0.27 ± 0.02 | 0.026a |
| ch-ch/z-z | |||
| Selimoglu et al. (16) | 0.36 ± 0.08 | 0.40 ± 0.08 | < 0.0001a |
| Present study | 0.36 ± 0.03 | 0.38 ± 0.03 | 0.001a |
| t-n/n-sn | |||
| Zanchi et al. (18) | 1.35 ± 0.19 | 1.34 ± 0.19 | 0.920 |
| Present study | 1.14 ± 0.18 | 1.13 ± 0.15 | 0.845 |
aSignificant at 0.05 level


